86 related articles for article (PubMed ID: 3977939)
21. A facile route to semi-synthesis of acetyl glycerylether phosphoethanolamine and its choline analogue.
Kumar R; Weintraub ST; McManus LM; Pinckard RN; Hanahan DJ
J Lipid Res; 1984 Feb; 25(2):198-208. PubMed ID: 6707528
[TBL] [Abstract][Full Text] [Related]
22. Cooperativity between platelet-activating factor and collagen in platelet aggregation.
Kojima S; Hagiwara H; Soga W; Sekiya F; Saito Y; Inada Y
Biochem Biophys Res Commun; 1987 Jun; 145(2):915-20. PubMed ID: 3593379
[TBL] [Abstract][Full Text] [Related]
23. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).
Demopoulos CA; Pinckard RN; Hanahan DJ
J Biol Chem; 1979 Oct; 254(19):9355-8. PubMed ID: 489536
[TBL] [Abstract][Full Text] [Related]
24. Paf-acether formation and arachidonic acid freeing from platelet ether-linked glyceryl-phosphorylcholine.
Chignard M; Le Couedic JP; Coëffier E; Benveniste J
Biochem Biophys Res Commun; 1984 Oct; 124(2):637-43. PubMed ID: 6437404
[TBL] [Abstract][Full Text] [Related]
25. Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187.
Oda M; Satouchi K; Yasunaga K; Saito K
J Immunol; 1985 Feb; 134(2):1090-3. PubMed ID: 3917470
[TBL] [Abstract][Full Text] [Related]
26. Human platelet stimulation by acetyl glyceryl ether phosphorylcholine.
McManus LM; Hanahan DJ; Pinckard RN
J Clin Invest; 1981 Mar; 67(3):903-6. PubMed ID: 7204562
[TBL] [Abstract][Full Text] [Related]
27. Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro.
Michel L; Denizot Y; Thomas Y; Jean-Louis F; Pitton C; Benveniste J; Dubertret L
J Immunol; 1988 Aug; 141(3):948-53. PubMed ID: 3397536
[TBL] [Abstract][Full Text] [Related]
28. Application of selected ion monitoring to determination of platelet-activating factor.
Satouchi K; Oda M; Yasunaga K; Saito K
J Biochem; 1983 Dec; 94(6):2067-70. PubMed ID: 6423622
[TBL] [Abstract][Full Text] [Related]
29. Functional and biochemical characterization of immunologically derived equine platelet-activating factor.
Wimberly HC; Slauson DO; Neilsen NR
Vet Pathol; 1985 Jul; 22(4):375-86. PubMed ID: 4035942
[TBL] [Abstract][Full Text] [Related]
30. Presence in normal human urine of a hypotensive and platelet-activating phospholipid.
Sánchez-Crespo M; Iñarrea P; Alvarez V; Alonso F; Egido J; Hernando L
Am J Physiol; 1983 Jun; 244(6):F706-11. PubMed ID: 6859262
[TBL] [Abstract][Full Text] [Related]
31. Analysis of effector cell-derived lyso platelet activating factor by electron capture negative ion mass spectrometry.
Christman BW; Gay JC; Christman JW; Prakash C; Blair IA
Biol Mass Spectrom; 1991 Sep; 20(9):545-52. PubMed ID: 1782204
[TBL] [Abstract][Full Text] [Related]
32. Response of mice and mouse platelets to acetyl glyceryl ether phosphorylcholine.
Lanara E; Vakirtzi-Lemonias C; Kritikou L; Demopoulos CA
Biochem Biophys Res Commun; 1982 Dec; 109(4):1148-56. PubMed ID: 7168759
[No Abstract] [Full Text] [Related]
33. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.
McManus LM; Hanahan DJ; Demopoulos CA; Pinckard RN
J Immunol; 1980 Jun; 124(6):2919-24. PubMed ID: 7373056
[No Abstract] [Full Text] [Related]
34. Platelet-activating factor biosynthesis in rat vascular smooth muscle cells.
Tomlinson PR; Croft K; Harris T; Stewart AG
J Vasc Res; 1994; 31(3):144-52. PubMed ID: 8148465
[TBL] [Abstract][Full Text] [Related]
35. Effect of rat phosphorylcholine-binding protein on platelet aggregation.
Nagpurkar A; Randell E; Choudhury S; Mookerjea S
Biochim Biophys Acta; 1988 Oct; 967(1):76-81. PubMed ID: 3167098
[TBL] [Abstract][Full Text] [Related]
36. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells.
Schlondorff D; Goldwasser P; Neuwirth R; Satriano JA; Clay KL
Am J Physiol; 1986 Jun; 250(6 Pt 2):F1123-7. PubMed ID: 3087218
[TBL] [Abstract][Full Text] [Related]
37. Kinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit.
McManus LM; Pinckard RN
Am J Pathol; 1985 Oct; 121(1):55-68. PubMed ID: 4050977
[TBL] [Abstract][Full Text] [Related]
38. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
Grigoriadis G; Stewart AG
Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
[TBL] [Abstract][Full Text] [Related]
39. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds.
Hogaboam CM; Donigi-Gale D; Shoupe TS; Bissonnette EY; Befus AD; Wallace JL
Br J Pharmacol; 1992 Jan; 105(1):87-92. PubMed ID: 1596692
[TBL] [Abstract][Full Text] [Related]
40. Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells.
Triggiani M; Schleimer RP; Warner JA; Chilton FH
J Immunol; 1991 Jul; 147(2):660-6. PubMed ID: 2071900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
